metastatic uveal melanoma show durable response to ipilimumab and nivolumab combination after pd-1
Published 3 years ago • 75 plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
4:29
anti–pd-1 therapy in metastatic melanoma
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
41:36
treatment of primary and metastatic uveal melanoma by dan gombos, md
-
1:28
dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
-
16:57
progress in treatment of metastatic uveal melanoma
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
7:00
metastatic melanoma: the immunotherapy approach
-
1:06
current and future treatment options for uveal melanoma
-
1:30
risk factors in uveal melanoma
-
4:25
the phenomenon of immunotherapy in melanoma
-
1:25
dr. ott discusses ipilimumab and nivolumab in melanoma
-
0:27
metastatic melanoma
-
27:01
immunotherapy for advanced melanoma
-
9:02
pd1/ ctla4 : upfront or sequentially?
-
1:00:03
first fda approval for metastatic uveal melanoma: what it means for the om community
-
2:32
from mole to metastatic: the different stages of melanoma
-
0:32
stages of melanoma
-
46:40
iclio webinar: therapeutic approaches to metastatic melanoma